Currently predicting for Thu, 4 Jun 2026

NVCR Prediction Chart

NVCR Predictions History

Latest community submissions for NVCR.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Dec 27, 2019 $86.83 -0.83% $87.56 X 99.17% 2
Chaser Chaser Pro
Dec 27, 2019 $89.34 +2.03% $87.56 X 97.97% 1
Nov 14, 2019 Bearish $82.42 X 0
JS JS Pro
Oct 18, 2019 $78.76 +5.11% $74.93 X 94.89% 0
Oct 18, 2019 Bullish $74.93 X 0
Alan Alan Pro @Alan.115878
Sep 4, 2019 $89.35 +5.85% $84.41 X 94.15% 0
Alan Alan Pro @Alan.115878
Sep 2, 2019 $93.19 +2.56% $90.86 X 97.44% 0
Alan Alan Pro @Alan.115878
Aug 30, 2019 $92.92 +2.27% $90.86 X 97.73% 0
Alan Alan Pro @Alan.115878
Aug 29, 2019 $92.73 +1.17% $91.66 X 98.83% 1
Alan Alan Pro @Alan.115878
Aug 28, 2019 $94.25 +4.90% $89.85 X 95.10% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVCR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVOCURE LIMITED
NovoCure
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE